Literature DB >> 9075452

Compliance with influenza vaccination. Its relation with epidemiologic and sociopsychological factors.

G A van Essen1, M M Kuyvenhoven, R A de Melker.   

Abstract

OBJECTIVE: To identify patient characteristics that are associated with compliance with influenza vaccination reminders in high-risk patients.
DESIGN: Registration of the vaccination of high-risk patients invited by their family physicians. Factors that might be associated with compliance were evaluated, eg, sex, age, insurance, diagnosis, seriousness, and multiple indications. A questionnaire about sociopsychological factors was sent to all noncompliant patients and a random sample of 25% of compliant patients.
SETTING: Four single and 3 partnership practices with 2142 high-risk patients in a total of 26,000 patients in the Netherlands. MAIN OUTCOME MEASURES: (1) Compliance by at-risk group; odds ratios (ORs) for epidemiologic and diagnosis-based factors, adjusted by multiple logistic regression analysis; (2) adjusted ORs (adj ORs) for sociopsychological factors; and (3) decisive reason whether to comply.
RESULTS: Compliance was 86% (95% confidence interval [CI], 85%-88%), with little difference between at-risk groups. The epidemiologic factors age older than 50 years (adj OR, 1.9; 95% CI, 1.5-2.5) and multiple indication (adj OR, 2.2; 95% CI, 1.3-3.6) were related to compliance, independent of at-risk group. Belief in the absence of side effects (adj OR, 10.5; 95% CI, 5.5-20.2) and in the efficacy of the vaccine (adj OR, 5.6; 95% CI, 3.0-10.2) were most positively associated with compliance. Perceived susceptibility to influenza also was associated (adj OR, 2.9; 95% CI, 1.5-5.8), but perception of one's health was not. There was a negative association of compliance in the interaction of age younger than 50 years and disbelief in the possible complications of influenza (adj OR, 0.2; 95% CI, 0.0-0.5). These factors and the family physician's invitation were decisive.
CONCLUSIONS: Information about the protection and the side effects of vaccination and the complications of influenza should be directed to patients younger than 50 years; no specific high-risk groups require special information.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9075452     DOI: 10.1001/archfami.6.2.157

Source DB:  PubMed          Journal:  Arch Fam Med        ISSN: 1063-3987


  9 in total

Review 1.  Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications.

Authors:  E Hak; Th J M Verheij; D E Grobbee; K L Nichol; A W Hoes
Journal:  J Epidemiol Community Health       Date:  2002-12       Impact factor: 3.710

2.  The causes of racial and ethnic differences in influenza vaccination rates among elderly Medicare beneficiaries.

Authors:  Paul L Hebert; Kevin D Frick; Robert L Kane; A Marshall McBean
Journal:  Health Serv Res       Date:  2005-04       Impact factor: 3.402

3.  Influenza vaccination in patients with asthma: why is the uptake so low?

Authors:  Helen Keenan; John Campbell; Philip H Evans
Journal:  Br J Gen Pract       Date:  2007-05       Impact factor: 5.386

4.  A qualitative study of lay beliefs about influenza immunisation in older people.

Authors:  Meirion R Evans; Hayley Prout; Lindsay Prior; Lorna M Tapper-Jones; Chris C Butler
Journal:  Br J Gen Pract       Date:  2007-05       Impact factor: 5.386

5.  Factors associated with uptake of influenza vaccine in people aged 50 to 64 years in Hong Kong: a case-control study.

Authors:  May Ps Yeung; Stephen Kam-Cheung Ng; Edmond Tak Fai Tong; Stephen Sek-Kam Chan; Richard Coker
Journal:  BMC Public Health       Date:  2015-07-07       Impact factor: 3.295

6.  Effectiveness of seasonal influenza vaccination in patients with diabetes: protocol for a nested case-control study.

Authors:  Ludovic Casanova; Sébastien Cortaredona; Jean Gaudart; Odile Launay; Philippe Vanhems; Patrick Villani; Pierre Verger
Journal:  BMJ Open       Date:  2017-08-18       Impact factor: 2.692

7.  Cross-sectional study on influenza vaccination, Germany, 1999-2000.

Authors:  Sybille Rehmet; Andrea Ammon; Günter Pfaff; Nikolaus Bocter; Lyle R Petersen
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

8.  Seasonal influenza vaccination coverage rate of target groups in selected cities and provinces in China by season (2009/10 to 2011/12).

Authors:  Lei Zhou; Qiru Su; Zhen Xu; Ao Feng; Hui Jin; Shiyuan Wang; Zijian Feng
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

9.  Health education and factors influencing acceptance of and willingness to pay for influenza vaccination among older adults.

Authors:  Rawipun Worasathit; Wantanee Wattana; Kamolnetr Okanurak; Archin Songthap; Jittima Dhitavat; Punnee Pitisuttithum
Journal:  BMC Geriatr       Date:  2015-10-26       Impact factor: 3.921

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.